First Recurrent GBM Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

Al's Comment:

 This is exciting. Novocure is testing a high intensity version of Optune on recurrent gbm  There are also about 26 clinical trials going on for Optune looking at it's use in other diseases and for glioblastomas combined with radiation, checkpoint inhibitors and other drugs!


Posted on: 07/22/2020

First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

 


Click HERE to return to brain tumor news headlines